
A new report by the American Life League uncovered a trend of “DIY abortions” using abortion-inducing drugs stashed in public places.


A new report by the American Life League uncovered a trend of “DIY abortions” using abortion-inducing drugs stashed in public places.



NASA test pilot Mike Lippert poses for a photo ahead of his first time flying the agency’s X-59 quiet supersonic research aircraft on Oct. 21, 2026.
Read More
“No clinical reasons why it should not take place,” said Dr. Stefano Margaritora, who called Pope Leo “an ideal patient.”

![Catholic lung cancer specialists weigh in on Pope Leo XIV’s diagnosis #Catholic Representatives of the American Lung Association and the Catholic Medical Association (CMA) discussed possible underlying causes of Pope Leo XIVʼs lung cancer and potential treatment options.Dr. Jeff McGovern, a pulmonologist, and Dr. Juanita Mora, spokesperson for the American Lung Association, appeared on “EWTN News Nightly” on Oct. 14 to discuss the Holy Father’s health following surgery. The Oct. 13 surgery involved the removal of the lower lobe of his right lung and confirmed a diagnosis of lung adenocarcinoma.“It is the most common cause of lung cancer in smokers and nonsmokers,” said McGovern, a CMA member. He said “treatments can be varying depending on the size,” and can involve chemotherapy, immunotherapy, or radiation in addition to the surgical removal of the lower part of the lung.The type of ongoing treatment the pope receives will depend on the results of a pathology test, which will reveal the stage of the cancer and whether it is contained or has spread to other areas, McGovern said.The pathology test “usually takes a couple of days,” or sometimes even longer, he said, but noted that because the patient is the Holy Father, “I would expect the pathology would be available a lot sooner than usual.”“In the best of all possible worlds, if it is contained, then going forward, as far as treatment, itʼs a CT scan every six months and then after about two or three years, a year thereafter. And that would be the treatment, and that would be the ideal setting for the Holy Father,” he said.Mora, a Catholic who is also from Chicago, Pope Leo’s hometown, said if the Holy Father’s pathology report reveals that the cancer has not spread, the survival rate is 80% to 90%. A spread would determine “whether he will get chemotherapy, radiotherapy or whether he will need actual immunotherapy thatʼs geared exactly to the biomarkers of the tumor that turn positive.” Mora said the Holy Father is “someone who is active,” playing tennis and staying in shape. “He’s a 71-year-old healthy, strong man. This is what Pope Leo has going for him,” she said. “We know that heʼs going to be at higher risk for some viral respiratory infections,” she said. “So, it is important for him to get his Covid-19 vaccine, his flu vaccine, and his RSV vaccine for those that are eligible.”In terms of travel, Mora said his doctors may determine he needs anticoagulation, or blood thinners, “so that heʼs at less risk of developing any clots, especially with the long flight that he has, [as well as] all the respiratory virus infections.”By the numbers: Impact of lung cancer“One person is diagnosed with lung cancer every 2.5 minutes,” Mora said. “In the United States, we lose 238,000 people a year due to lung cancer. And itʼs the No. 1 cause of mortality from cancer in both men and women in the United States.”In addition to smoking, Mora highlighted several other causes of lung cancer, including radon gas, “a colorless, odorless gas that can seep in through cracks in our ground, in our home, or through cracks in walls,” ozone pollution, and particle contamination. Catholic lung cancer specialists weigh in on Pope Leo XIV’s diagnosis #Catholic Representatives of the American Lung Association and the Catholic Medical Association (CMA) discussed possible underlying causes of Pope Leo XIVʼs lung cancer and potential treatment options.Dr. Jeff McGovern, a pulmonologist, and Dr. Juanita Mora, spokesperson for the American Lung Association, appeared on “EWTN News Nightly” on Oct. 14 to discuss the Holy Father’s health following surgery. The Oct. 13 surgery involved the removal of the lower lobe of his right lung and confirmed a diagnosis of lung adenocarcinoma.“It is the most common cause of lung cancer in smokers and nonsmokers,” said McGovern, a CMA member. He said “treatments can be varying depending on the size,” and can involve chemotherapy, immunotherapy, or radiation in addition to the surgical removal of the lower part of the lung.The type of ongoing treatment the pope receives will depend on the results of a pathology test, which will reveal the stage of the cancer and whether it is contained or has spread to other areas, McGovern said.The pathology test “usually takes a couple of days,” or sometimes even longer, he said, but noted that because the patient is the Holy Father, “I would expect the pathology would be available a lot sooner than usual.”“In the best of all possible worlds, if it is contained, then going forward, as far as treatment, itʼs a CT scan every six months and then after about two or three years, a year thereafter. And that would be the treatment, and that would be the ideal setting for the Holy Father,” he said.Mora, a Catholic who is also from Chicago, Pope Leo’s hometown, said if the Holy Father’s pathology report reveals that the cancer has not spread, the survival rate is 80% to 90%. A spread would determine “whether he will get chemotherapy, radiotherapy or whether he will need actual immunotherapy thatʼs geared exactly to the biomarkers of the tumor that turn positive.” Mora said the Holy Father is “someone who is active,” playing tennis and staying in shape. “He’s a 71-year-old healthy, strong man. This is what Pope Leo has going for him,” she said. “We know that heʼs going to be at higher risk for some viral respiratory infections,” she said. “So, it is important for him to get his Covid-19 vaccine, his flu vaccine, and his RSV vaccine for those that are eligible.”In terms of travel, Mora said his doctors may determine he needs anticoagulation, or blood thinners, “so that heʼs at less risk of developing any clots, especially with the long flight that he has, [as well as] all the respiratory virus infections.”By the numbers: Impact of lung cancer“One person is diagnosed with lung cancer every 2.5 minutes,” Mora said. “In the United States, we lose 238,000 people a year due to lung cancer. And itʼs the No. 1 cause of mortality from cancer in both men and women in the United States.”In addition to smoking, Mora highlighted several other causes of lung cancer, including radon gas, “a colorless, odorless gas that can seep in through cracks in our ground, in our home, or through cracks in walls,” ozone pollution, and particle contamination.](https://unitedyam.com/wp-content/uploads/2026/10/catholic-lung-cancer-specialists-weigh-in-on-pope-leo-xivs-diagnosis-catholic-representatives-of-the-american-lung-association-and-the-catholic-medical-association-cma-discussed-possible-u.png)
“It is the most common cause of lung cancer in smokers and nonsmokers,” said Jeff McGovern, a pulmonologist, about Pope Leo’s diagnosis.



An engineering model of NASA’s DAVINCI (Deep Atmosphere Venus Investigation of Noble gases, Chemistry, and Imaging) descent probe passed a key test that ran from Aug. 28 to Sept. 10, showing it can survive the extreme temperatures of Venus.
Read More
New civil servants and guests pose for a group photo with NASA and Center leadership in the National Full-Scale Aerodynamics Complex (NFAC) 80-by-120-foot test section, N221.
Read More

NASA astronaut and Expedition 75 commander Jessica Meir wears a set of virtual reality goggles, also called the Nevada Screening Vision System, for a test that measures visual function using a series of vision screening apps testing visual acuity, contrast sensitivity, and more.
Read More
NASA opened its newest wind tunnel, the Flight Dynamics Research Facility at NASA’s Langley Research Center in Hampton, Virginia, on Friday, providing a critical resource for the agency and its partners to test the safety and performance of future generations of aircraft, rockets, and space exploration vehicles.
Read More
Crews at NASA’s Michoud Assembly Facility in New Orleans transport the 130-foot-tall liquid hydrogen tank out of a production cell inside the main factory building into a detached test building on a separate portion of the 829-acre site.
Read More

NASA announced the Artemis III crew on Tuesday, June 9, 2026. NASA astronaut Andre Douglas, mission specialist; ESA (European Space Agency) astronaut Luca Parmitano, pilot; NASA astronaut Randy Bresnik, commander; and NASA astronaut Frank Rubio, mission specialist, will demonstrate the Orion spacecraft’s rendezvous and docking capabilities with test versions from one, or both, American commercial human landing systems in development by Blue Origin and SpaceX.
Read More
The Orion Crew Survival System suits that Commander Reid Wiseman, Pilot Victor Glover, and Mission Specialist Christina Koch from NASA, and Mission Specialist Jeremy Hansen from the CSA (Canadian Space Agency) will wear on the Artemis II test flight are seen in the suit-up room of the Neil A. Armstrong Operations and Checkout Building, Saturday, Jan. 17, 2026, at NASA’s Kennedy Space Center in Florida.
Read More

Off the coast of California, NASA’s Artemis Landing and Recovery team and the Department of War that will work together to retrieve the Artemis II crew and Orion spacecraft following their return to Earth and splashdown in the Pacific Ocean are performing a final simulation of their activities, called a just-in-time training, at sea on Tuesday, Jan. 27, 2026. During the training, teams use the Crew Module Test Article, a full-scale mockup of the Orion spacecraft, to simulate as close as possible the conditions they can expect to encounter during splashdown of the Artemis II mission.
Read More
The Carbothermal Reduction Demonstration (CaRD) project aims to demonstrate the carbothermal reduction of lunar regolith to produce oxygen on the Moon’s South Pole. For this test, the team integrated the solar concentrator, mirrors, and software and confirmed the production of carbon monoxide.
Read More

Artemis II crewmembers (left to right) NASA astronauts Christina Koch, mission specialist; and Victor Glover, pilot; CSA (Canadian Space Agency) astronaut Jeremy Hansen, mission specialist; and NASA astronaut Reid Wiseman, commander are led to the crew access arm as they prepare to board their Orion spacecraft atop NASA’s Space Launch System rocket during the Artemis II countdown demonstration test on Dec. 20, 2025.
Read More

From left to right, CSA (Canadian Space Agency) astronaut Jeremy Hansen and NASA astronauts Christina Koch, Victor Glover, and Reid Wiseman are seen as they depart the Neil A. Armstrong Operations and Checkout Building to board their Orion spacecraft atop NASA’s Space Launch System rocket inside the Vehicle Assembly Building as part of the Artemis II countdown demonstration test, Saturday, Dec. 20, 2025, at NASA’s Kennedy Space Center in Florida.
Read More

Researchers from NASA’s Jet Propulsion Laboratory in Southern California monitor a research drone in the Dumont Dunes area of the Mojave Desert in September 2025 as part of a test campaign to develop navigation software to guide future rotorcraft on Mars.
Read More